Immediate Impact

1 from Science/Nature 44 standout
Sub-graph 1 of 20

Citing Papers

Nanotechnology in healthcare, and its safety and environmental risks
2024 Standout
Multifunctional nanoparticle-mediated combining therapy for human diseases
2024 Standout
1 intermediate paper

Works of Krishnamurthy Sekar being referenced

A Randomized, Multicenter Masked Comparison Trial of Poractant Alfa (Curosurf) versus Beractant (Survanta) in the Treatment of Respiratory Distress Syndrome in Preterm Infants
2004

Author Peers

Author Last Decade Papers Cites
Krishnamurthy Sekar 380 215 55 115 13 432
David Z. Myerberg 261 125 120 71 16 385
Hung‐Mo Lin 407 63 104 173 19 499
A Mithal 319 56 44 270 11 413
Anne B. Fletcher 308 83 183 199 14 441
Hyo Soon An 311 36 28 230 21 415
Alberto Ricotti 153 51 91 115 13 423
Machiko Ikegami 387 169 94 162 13 491
Aaron Chiu 334 142 48 155 14 403
Piero Giuseppe Matassa 334 79 58 187 19 384
Nael Elias 241 28 29 72 21 374

All Works

Loading papers...

Rankless by CCL
2026